Propelling Oncology Research Onward

Comfortable with Complexity

We are dedicated to supporting increasingly sophisticated research in this innovative field. Our mobile, minimally invasive biospecimen and data collection capabilities are ideally suited for detecting biomarkers in circulation, investigating concepts in immunotherapy, and for ex vivo drug screening in oncology research. Meanwhile, our access to the cancer patient community ensures you can reach, recruit, and retain the participants you need.

  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Essential Thrombocythemia
  • Kidney Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelofibrosis
  • Ovarian Cancer
  • Pancreatic Cancer
  • Polycythemia Vera
  • Prostate Cancer
  • Skin Cancer

Sanguine's Expertise in Oncology


Patient Members


Studies Completed


Contact us to discuss your research needs

Sanguine Services

  • Whole Blood
  • Serum
  • Plasma
  • Urine (Lupus Nephritis)
  • Skin Taping (Atopic Derm)
  • PBMCs (+ Derivatives)
  • Hair
  • Stool
  • Semen
  • Nails
  • Buffy Coat
  • PBMC isolation
  • Serum and plasma isolation
  • T cell isolation
  • B cell isolation
  • Natural killer cell isolation
  • Urine processing
  • Genotype and mutation status (ex: CALR, JAK2)
  • Active disease
  • Staging status and history
  • "Treatment history (Ex: Ruxolitinib for MF, checkpoint inhibitors, I-O therpay, chemotherapy, radiation therapy, combination therapy)"
  • Disease Confirmation
  • Covid-19 (PCR)
  • HIV/HPV/Hepatitis/Herpes Etc.
  • BioMarker Quantification
  • CBC, Platelett, & Diff
  • CRP
  • Cal-Protecin
  • ANA
  • Cytokine Panel
  • BUN
  • Urinalysis
  • Thyroid Stimulating Hormone
  • Lipid Panel
  • LDH
  • Genetic Analysis
  • HLA Typing
  • dsDNA
  • RNA Vial Load Qaunitification
  • Matched healthy controls

Recent therapeutic advancements have already given oncology patients, especially those with advanced or relapsed disease, new life-extending options, and that progress promises to continue. Our fully integrated services enhance the pharmaceutical industry’s ability to meet the unique demands of oncology research. Moreover, our patient-centric approach assures you a comprehensive view of disease, through biospecimens and data that includes quality-of-life surveys and questionnaires. Above all, we seek to create new opportunities for you to advance vital research that lengthens and improves patients’ lives. 


How the Direct-to-Patient Approach can Streamline your Research Study and Trials

COVID-19 - Thumbnail

Multi-Collection Capabilities:
Powering Microbiome Discovery in Cancer Research

Hear From Our Community


"I chose to participate in Sanguine projects because I will never say no to helping with research to cure melanoma. The best and easiest part of the program was that Sanguine sent a nurse to me to make it so convenient!"



“I was more than happy to participate if it could help others with lung cancer.”